Loading clinical trials...
Loading clinical trials...
Anlotinib Hydrochloride Therapy in Patients With Advanced Lung Cancer: A Real World Study.
Conditions
Interventions
Anlotinib Hydrochloride
Locations
1
China
First People's Hospital of Hangzhou
Hangzhou, Zhejiang, China
Start Date
May 1, 2019
Primary Completion Date
May 1, 2020
Completion Date
December 1, 2020
Last Updated
May 7, 2019
NCT07143110
NCT06885697
NCT04577599
NCT06974604
NCT07035587
NCT04631770
Lead Sponsor
First People's Hospital of Hangzhou
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions